Trial intelligence / Profile preview

Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound

NCT05617872Completed

Sponsor
Peking Union Medical College Hospital
Start
Dec 2022
Primary completion
May 2025
Countries
1
01

Overview

Randomised trial of acetic acid in pancreatic cancer (PC) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: KRAS mutation at 6 months. Started Dec 2022; status: completed.

02

Drugs

acetic acid
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT05617872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05617872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call